Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Kanghua Zhonglian Cardiovascular Hospital is a specialized Grade III cardiovascular hospital located in the Jiangbei District of Chongqing, China. It was established as a collaborative effort involving the expertise of the Wuhan Asia Heart Hospital to provide advanced cardiac care to the Southwest China region. The hospital offers a full range of services including cardiac surgery, interventional cardiology, and pediatric heart care. It is equipped with state-of-the-art medical technology, such as hybrid operating rooms and advanced imaging systems, to perform complex procedures like heart transplants and minimally invasive valve surgeries. As a major regional heart center, it focuses on clinical excellence, medical research, and the training of cardiovascular specialists. The facility serves as a critical hub for heart health, integrating prevention, treatment, and rehabilitation services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Kanghua Zhonglian Cardiovascular Hospital.